Foley Hoag, Latham Lead RNA Tech Co.'s $1.2B SPAC Merger

By Tom Zanki (August 10, 2021, 6:15 PM EDT) -- RNA technology firm GreenLight Biosciences Inc. will go public at an estimated $1.2 billion valuation by merging with blank-check company Environmental Impact Acquisition Corp. in a deal announced Tuesday under guidance from Foley Hoag and Latham.

Massachusetts-based GreenLight, a maker of vaccines and alternative pesticides, expects to list on the Nasdaq, assuming shareholders and regulators approve the merger, which is expected to close in the fourth quarter of 2021. Foley Hoag LLP is representing GreenLight while Latham & Watkins LLP is advising Environmental Impact.

GreenLight is set to receive $282 million in proceeds from the merger, including money raised in a...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!